Health Care

Employers lose $160 billion each year thanks to workers coming into the office while sick, according to research conducted in 2014.

The fiasco of Samsung's fire-prone Galaxy Note 7 smartphones — and Samsung's stumbling response to the problem — has left consumers from Shanghai to New York reconsidering how they feel about the South Korean tech giant and its products.

Worries about the safety of Samsung's replacement Galaxy Note 7 smartphones have consumers fretting about what to do.

Shares of health-care companies fell as a victory for Hillary Clinton the U.S. presidential election looked increasingly likely.

Samsung Electronics says it is stopping production of its Galaxy Note 7 smartphones, a day after it halted global sales of the star-crossed devices.

Samsung's global recall of 2.5 million Note 7 smartphones and the decision to cease production ranks among the largest product failures in recent memory.

The average retired couple should plan to spend at least a quarter million dollars on healthcare.

One of Theranos Inc.'s biggest financial backers has sued the embattled startup and its founder for allegedly lying to attract its nearly $100 million investment, according to a fund document and people familiar with the matter.

Blue Bell Creameries is recalling all of its ice cream products that contain cookie dough from an Iowa-based supplier.

Turkey Hill is recalling some mislabeled packages of ice cream.

Mylan will pay $465 million to settle allegations that it overbilled Medicaid for its life-saving EpiPen allergy injection.

A&T will stop exchanging Samsung Galaxy Note 7 smartphones because of reports that some of the replacement phones are catching fire, just as the original phones did before they were recalled last month.

Samsung Electronics seemed to have its smartphone troubles under control — until authorities had to evacuate a Southwest Airlines flight in Kentucky last week for an incident that involved a replacement phone.

A line of children's nightgowns that fail to meet flammability standards are among this week's recalled consumer products.

Mylan said it agreed to a $465 million settlement with the U.S. Department of Justice related to the manner in which it had improperly classified its EpiPen emergency allergy treatment to pay lower rebates to state health programs.

With the Watson Health Cloud, IBM is building an ever-growing Cloud-based repository of health-related data with the goal of improving population health.

U.S. government health plans spent more than $1 billion on Mylan NV's EpiPen emergency allergic reaction treatment between 2011 and 2015, according to figures released by the Centers for Medicare and Medicaid Services on Wednesday.